4-(azidomethyl)-3,5-dimethylisoxazole | 1007468-52-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-(azidomethyl)-3,5-dimethylisoxazole
• 英文别名: 4-(Azidomethyl)-3,5-dimethyl-1,2-oxazole
• CAS: 1007468-52-1
• 化学式: C₆H₈N₄O
• 分子量: 152.156
• InChiKey: XDJYXPPOXPCMAJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  40.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-(azidomethyl)-3,5-dimethylisoxazole 、 二(三甲基甲硅烷基)乙炔 以 甲苯 为溶剂， 反应 72.0h， 以85%的产率得到4-((4,5-bis(trimethylsilyl)-1H-1,2,3-triazol-1-yl)methyl)-3,5-dimethylisoxazole
  参考文献：
  名称：

  Thermal, non-catalyzed Huisgen cycloaddition for the preparation of 4,5-bis(trimethylsilyl)-1H-1,2,3-triazoles

  摘要：

  The 1,2,3-triazole scaffold is an important pharmacophore and a versatile, increasingly leveraged, sub-structure in biochemical, materials, polymer, and metal-coordinating applications. Continuing advances in 1,2,3-triazole construction, by either non-catalyzed or metal-catalyzed azide/alkyne cycloaddition, foster further creative use. The work reported here establishes a general protocol for the synthesis of 4,5-bis(trimethylsilyl)-1H-1,2,3-triazoles via thermal Huisgen cycloaddition between azides and bis(trimethylsilyl)acetylene. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2012.11.019

文献信息

• [EN] SPIROHYDANTOIN COMPOUNDS AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS<br/>[FR] COMPOSÉS DE SPIROHYDANTOÏNE ET LEUR UTILISATION COMME MODULATEURS SÉLECTIFS DES RÉCEPTEURS DES ANDROGÈNES
  申请人：NOVARTIS AG

  公开号：WO2013128421A1

  公开（公告）日：2013-09-06

  The present invention relates to a compound of formula (1-1 ) in free form or in pharmaceutically acceptable salt form in which the substituents are as defined in the specification; to its preparation, to its use as a medicament and to medicaments comprising it. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明涉及一种化合物，其化学式为(1-1)，其以自由形式或药用可接受盐形式存在，其中取代基如规范中所定义；涉及其制备，其用作药物以及包含它的药物。本发明还提供了一种药理活性剂的组合和药物组成。
• Spirohydantoin compounds and their use as selective androgen receptor modulators
  申请人：NOVARTIS AG

  公开号：US20150299120A1

  公开（公告）日：2015-10-22

  The present invention relates to a compound of formula (I-1) in free form or in pharmaceutically acceptable salt form in which the substituents are as defined in the specification; to its preparation, to its use as a medicament and to medicaments comprising it. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明涉及一种式子为(I-1)的化合物，其以自由形式或药学上可接受的盐形式存在，其中取代基如规范中定义；以及其制备方法、用作药物的方法和含有该化合物的药物。本发明还提供了一种药理活性剂的组合和制药组合物。
• SPIROHYDANTOIN COMPOUNDS AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS
  申请人：Novartis AG

  公开号：EP2819999A1

  公开（公告）日：2015-01-07